Screening for Atrial Fibrillation: Risks, Benefits, and implications on
future clinical practice.
Abstract
Atrial fibrillation (AF) is the most common arrhythmia in clinical
practice. The prevalence of AF is known to be constantly rising due to
an overall increased ageing population with multiple co-morbidities in
the Western world, predisposing to debilitating complications such as
stroke and coronary artery disease (CAD). Therefore, there has been a
great interest in improving clinical outcomes for these patients. Hence,
various screening strategies have come into guidelines in order to
identify individuals at an increased risk of AF and its complications.
It is speculated that assessment of risk factors using various screening
tools will aid in improving outcomes and reducing AF-related
complications. Thereby, there has been a recognised need for
investigating the diagnostic accuracy of key index tests in the
diagnosis and management of AF.